1. He Z, Zhou J, Tian Y, Wu S, Sun Y, Ou X, Jia J, Wang B*, Wu X*, You H*.Two-year free of complications during antiviral therapy predicts stable re-compensation in immediate-treatment HBV-related decompensated cirrhosis.Scand J Gastroenterol.2022.13.1-9.SCI |
2. Wang P#, Cui Y#, Wang J, Liu D, Tian Y, Liu K, Wang X, Liu L, He Y, Pei Y, Li L, Sun L, Zhu Z, Chang D*, Jia J*, You H*.Mesenchymal stem cells protect against acetaminophen hepatotoxicity by secreting regenerative cytokine hepatocyte growth factor.Stem Cell Res Ther.2022.13(1).94.SCI |
3. Qi S#, Li J#, He X, Zhou J, Chen Z, Li X, Zhang B, Ma H*, You H*, Huang J*.Identification and Validation of Novel Serum Autoantibodies Biomarkers for Staging Liver Fibrosis in Patients With Chronic Hepatitis B.Front Med (Lausanne).2022.8.807087.SCI |
4. Tong XF#, Wang QY#, Zhao XY, Sun YM, Wu XN, Yang LL, Lu ZZ, Ou XJ, Jia JD, You H*.Histological assessment based on liver biopsy: the value and challenges in NASH drug development.Acta Pharmacol Sin.2022.43(5).1200-1209.SCI |
5. Wu S, Zhou J, Wu X, Sun Y, Wang B, Kong Y, Zhan S, Jia J, Yang HI, You H*.Comparative Performance of 14 HCC Prediction Models in CHB: A Dynamic Validation at Serial On-Treatment Timepoints.AMERICAN JOURNAL OF GASTROENTEROLOGY.2022.117(9).1444-1453.SCI |
6. Yang A#, Yan X#, Xu H, Fan X, Zhang M, Huang T, Li W, Chen W, Jia J, You H*.Selective depletion of hepatic stellate cells-specific LOXL1 alleviates liver fibrosis.FASEB J.2021.35(10).e21918.SCI |
7. Yang A, Yan X, Fan X, Shi Y, Huang T, Li W, Chen W, Jia J, You H*.Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice.Hepatol Int.2021.15(5).1122-1135.SCI |
8. Wu S, Zeng N, Sun F, Zhou J, Wu X, Sun Y, Wang B, Zhan S, Kong Y, Jia J, You H*, Yang HI*..Hepatocellular Carcinoma Prediction Models in Chronic Hepatitis B: A Systematic Review of 14 Models and External Validation..Clin Gastroenterol Hepatol.2021.19(12).2499-2513.SCI |
9. Chen S#, Zhou J#, Wu X, Meng T, Wang B, Liu H, Wang T, Zhao X, Kong Y, Wu S, Ou X, Jia J, Sun Y*, You H*..Comparison of fibrosis regression of entecavir alone or combined with pegylated interferon alpha2a in patients with chronic hepatitis B..Hepatol Int.2021.15(3).611-620.SCI |
10. Wang B, Zhou J, Wu X, Sun Y, Li L, Li P, Li M, Jiang W, Xu M, Feng B, Xu X, Cheng J, Xie W, Han T, Wang X, Li H, Piao H, Wu S, Shi Y, Chen S, Kong Y, Ma H, Ou X, Jia J*, You H*..Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSM..Liver Int.2021.41(2).369-377.SCI |
11. Wei Chen, Aiting Yang, Jidong Jia, Yury V Popov, Detlef Schuppan*, Hong You*.Lysyl oxidase (LOX) family members: rationale and their potential as therapeutic targets for liver fibrosis.Hepatology.2020.72(2).729-741.SCI |
12. Sun YM, Chen SY, You H*.Regression of liver fibrosis: evidence and challenges..Chin Med J (Engl).2020.133(14).1696-1702.SCI |
13. Sun Y, Wu X, Zhou J, Meng T, Wang B, Chen S, Liu H, Wang T, Zhao X, Wu S, Kong Y, Ou X, Wee A, Theise ND, Qiu C, Zhang W, Lu F, Jia J*, You H*..Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy..Clin Gastroenterol Hepatol.2020.18(11).2582-2591.e6..SCI |
14. Shi YW, Wang QY, Zhao XY, Sun YM, Kong YY, Ou XJ, Jia JD, Wu SS*, You H*..Non-obese NAFLD patients may use lower liver stiffness cut-off to better assess fibrosis stages..J Dig Dis.2020.21(5).279-286.SCI |
15. Wang B, Sun Y, Zhou J, Wu X, Chen S, Shi Y, Wu S, Liu H, Ren Y, Ou X, Jia J, You H*..SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies. .Hepatol Int.2019.13(4).501-509.SCI |
16. She S#, Wu X#, Zheng D, Pei X, Ma J, Sun Y, Zhou J, Nong L, Guo C, Lv P, Song Q, Zheng C, Liang W, Huang S, Li Q, Liu Z, Song Z, Li Y, Zhang Y, Kong W, You H*, Xi J*, Wang Y*..PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target..J Hepatol.2019.72(3).506-518.SCI |
17. Liu T, Sun Y, Zhou J, Yang F, Zou X, Wang L, Wu X, Chen Y, Piao H, Lu L, Jiang W, Xu Y, Feng B, Nan Y, Xie W, Chen G, Zheng H, Li H, Ding H, Liu H, Wang T, Ou X, Wu S, Kong Y, Wang P, Cong M, Zhang Y, You H*, Jia J*..On-treatment changes of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein are associated with the regression of liver fibrosis in chronic hepatitis B patients on interferon α add-on therapy. .J Med Virol.2019.91(8).1499-1509.SCI |
18. Kong Y, Sun Y, Zhou J, Wu X, Chen Y, Piao H, Lu L, Ding H, Nan Y, Jiang W, Xu .Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir. .J Viral Hepat.2019.26(5).576-585.SCI |
19. Sun Y, Zhou J, Wu X, Chen Y, Piao H, Lu L, Ding H, Nan Y, Jiang W, Wang T, Liu H, Ou X, Wee A, Theise ND, Jia J, You H*..Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak .Sci Rep.2018.8(1).2989.SCI |
20. Wu S, Kong Y, Piao H, Jiang W, Xie W, Chen Y, Lu L, Ma A, Xie S, Ding H, Shang J, Zhang X, Feng B, Han T, Xu X, Huo L, Cheng J, Li H, Wu X, Zhou J, Sun Y, Ou X, Zhang H, You H*, Jia J*..On-treatment changes of liver stiffness at week 26 could predict 2-year clinical outcomes in HBV-related compensated cirrhosis..Liver Int.2018.38(6).1045-1054.SCI |
21. Zhao W, Yang A, Chen W, Wang P, Liu T, Cong M, Xu A, Yan X, Jia J, You H*..Inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking..Biochim Biophys Acta..2018.1864.1129-1137..SCI |
22. Wu X#, Shi Y#, Zhou J, Sun Y, Piao H, Jiang W, Ma A, Chen Y, Xu M, Xie W, Cheng J, Xie S, Shang J, Cheng J, Xie Q, Ding H, Zhang X, Bai L, Zhang M, Wang B, Chen S, Ma H, Ou X, Jia J*, You H*..Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: A prospective multicenter randomized open-label study..Expert Opinion on Biological Therapy.2018.18(sup1).61-69.SCI |
23. Wu S, Yang Z, Zhou J, Zeng N, He Z, Zhan S, Jia J, You H*..Systematic review: diagnostic accuracy of non-invasive tests for staging liver fibrosis in autoimmune hepatitis..Hepatol Int.2018.13(1).91-101.SCI |
24. Wang B, Sun Y, Zhou J, Wu X, Chen S, Wu S, Liu H, Wang T, Ou X, Jia J, You H*..Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients..Mod Pathol.2018.31(10).1567-1577.SCI |
25. Wang P, Cong M, Liu T, Xu H, Wang L, Sun G, Yang A, Zhang D, Huang J, Sun Y, Zhao W, Ma H, Jia J*, You H*..Inhibitory effects of HNF4α on migration/maltransformation of hepatic progenitors: HNF4α-overexpressing hepatic progenitors for liver repopulation.Stem Cell Res Ther..2017.14;8.183.SCI |
26. Chen W#, Zhao W, Yang A, Xu A, Wang H, Cong M, Liu T, Wang P, You H*..Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis..Gene.2017.636.87-95.SCI |
27. Sun Y, Zhou J, Wang L, Wu X, Chen Y, Piao H, Lu L, Jiang W, Xu Y, Feng B, Nan Y, Xie W, Chen G, Zheng H, Li H, Ding H, Liu H, Lv F, Shao C, Wang T, Ou X, Wang B, Chen S, Wee A, Theise ND*, You H*, Jia J*..New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment..Hepatology..2017.65(5).1438-1450.SCI |
28. You H#, Kong Y#, Hou J, Wei L, Zhang Y, Niu J, Han T, Ou X, Dou X, Shang J, Tang H, Xie Q, Ding H, Ren H, Xu X, Xie W, Liu X, Xu Y, Li Y, Li J, Chow SC, Zhuang H, Jia J*..Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B..Sci Rep. .2016.6.37498. .SCI |
29. Yang AT, Hu DD, Wang P, Cong M, Liu TH, Zhang D, Sun YM, Zhao WS, Jia JD, You H*..TGF-β1 Induces the Dual Regulation of Hepatic Progenitor Cells with Both Anti- and Proliver Fibrosis.Stem Cells Int..2016.2016.1492694..SCI |
30. Wang P*, Yang AT, Cong M, Liu TH, Zhang D, Huang J, Tong XF, Zhu ST, Xu Y, Tang SZ, Wang BE, Ma H, Jia JD, You H*..EGF Suppresses the Initiation and Drives the Reversion of TGF-β1-induced Transition in Hepatic Oval Cells Showing the Plasticity of Progenitor Cells..J Cell Physiol..2015.230(10).2362-70.SCI |
31. Wu X, Jia J*, You H*..Thymosin alpha-1 treatment in chronic hepatitis B..Expert Opin Biol Ther.2015.2.1-4.SCI |
32. You H, Jia J*..Telbivudine treatment in chronic hepatitis B: experience from China..J Viral Hepat..2013.Suppl 1.3-8. .SCI |
33. Cong M, Liu T, Wang P, Fan X, Yang A, Bai Y, Peng Z, Wu P, Tong X, Chen J, Li H, Cong R, Tang S, Wang B, Jia J, You H*..Antifibrotic Effects of a Recombinant Adeno-Associated Virus Carrying Small Interfering RNA Targeting TIMP-1 in Rat Liver Fibrosis..Am J Pathol. .2013.3.1-8.SCI |
34. You H*, Wu X, Ou X, Ma H, Wang Q, Liu T, Cong M, Wang P, Wang B, Jia J..Two patterns of alanine aminotransferase increase to predict long-term viral response in chronic hepatitis B patients: virus- or host-induced? .Antiviral Therapy.2011.16.299-307.SCI |
35. Wang P, Cong M, Liu TH, Yang AT, Cong R, Wu P, Tang SZ, Xu Y, Wang H, Wang BE, Jia JD, You H(责任作者)*..Primary isolated hepatic oval cells maintain progenitor cell phenotypes after two-year prolonged cultivation.J Hepatol.2010.53(5).863-71.SCI |
36. Cong M, Liu T, Wang P, Xu Y, Tang S, Wang B, Jia J, Liu Y, Hermonat PL, You H.(责任作者)* .Suppression of tissue inhibitor of metalloproteinase-1 by recombinant adeno-associated viruses carrying siRNAs in hepatic stellate cells..Int J Mol Med..2009.24.685-692.SCI |
37. You H *, Ma H , Liu T, Cong M, Wang P, Ou XJ, Wang XM, Ren JB, Li HY, Wang BE and Jia JD*.Different models of HBeAg seroconversion predicated by on-treatment ALT and HBV DNA profiles..J Viral Hepatitis.2009.16.676-682.SCI |
38. Wang P, Liu TH, Cong M, Wu XN, Bai YF, Yin CH, An W, Wang BE, Jia JD, You H.(责任作者)*.Expression of Extracellular Matrix Genes in Cultured Hepatic Oval Cells: an origin of hepatic stellate cells through TGF beta.Liver Int..2009.29.575-584.SCI |
39. Tianhui Liu, Min Cong, Ping Wang, Jidong Jia, Yong Liu,Paul L. Hermonat,You H(责任作者)*. .Adeno-associated virus Rep78 protein inhibits hepatitis B virus replication through regulation of the HBV core promoter.BBRC.2009.385.106-111.SCI |
40. You H, Liu Y, Cong M, Ping W, You C, Zhang D, Mehta JL, Hermonat PL*..HBV genes induce cytotoxic T lymphocyte response upon adeno-associated virus (AAV) vector delivery into dendritic cells..J Viral Hepatitis.2006.13.605-612.SCI |